Patent ID: 6383735
Filing Date: 2002-05-07
Classification: G01N,G06K,G06T

Abstract:
A process for rapidly diagnosing Fibromyoma or carcinoma corporis uteri or their precursor stages, comprising the steps of:a) providing two blood samples of a patient of which one includes at least one of arterial and capillary blood (index A) and the other includes venous blood (index V), bi) determining for each sample the percentage share Ni of blood cells of a first group i=1, which includes blood cells of a size of 8 &mgr;m and smaller than 8 &mgr;m, bii) determining for each sample the percentage share Ni of blood cells of a second group i=2, which includes blood cells of a size of 9 &mgr;m and 10 &mgr;m, biii) determining for each sample the percentage share Ni of blood cells of a third group i=3, which includes blood cells of a size of 11 &mgr;m and greater than 11 &mgr;m, all on the basis of the total number of blood cells and for arterial and capillary blood [(Ni)A] as well as for venous blood [(Ni)V], c) multiplying the values obtained for [(Ni)A] and [(Ni)V] each with a weighting factor &agr;i=4, for the first and the third groups, and the weighting factor &agr;i=2 for the second group such that the values &agr;i[(Ni)A] and &agr;i[(Ni)V] are obtained, d) multiplying the values obtained for [(Ni)A] and [(Ni)V] each with a weighting factor &bgr;i=8 for the first group, a weighting factor &bgr;i=4 for the second group and a weighting factor &bgr;i=2 for the third group, whereby the values &bgr;i[(Ni)A and &bgr;i[(Ni)V are obtained, e) calculating the differences y=&Sgr;&agr;i[(Ni)A]âˆ’&Sgr;&agr;i[(Ni)V]andx=&Sgr;&bgr;i[(Ni)A]âˆ’&Sgr;&bgr;i[(Ni)V], andf) determining the deviation of the values x and y obtained from the blood samples of the patient from a comparative collection of the x and y values obtained from blood samples of healthy persons, and g) determining from the deviation of the values x and y from the respective values found in blood samples of healthy persons whether the patient is afflicted by fibromyoma or carcinoma corporis uteri or a precursor stage thereof.